Connect
MJA
MJA

Drug treatment for melanoma: progress, but who pays?

Sonia Fullerton
Med J Aust 2012; 197 (9): 491-492. || doi: 10.5694/mja12.11249
Published online: 5 November 2012

To the Editor: Kefford’s contention that making cancer drugs affordable requires coherent policy and cannot be left to market forces1 is correct.

  • Sonia Fullerton

  • Eastern Health, Melbourne, VIC.


Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.